The strategic realignment is aimed at better serving customers across the drug development lifecycle, from research and discovery to clinical and commercial manufacturing.
The CDMO’s new cold chain warehouse in Latina, which will be integrated directly into the manufacturing site, will go into operation in the first quarter of 2026.
